KATHRYN MCINTOSH: Open Payments
NPI 1942711528 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 41 payments from 12 companies in 2025. Trend: 2023 $1,316 · 2024 $1,269 · 2025 $1,053
Food & beverage: $953Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $335 |
| JAZZ PHARMACEUTICALS INC. | 6 | $244 |
| Verona Pharma, Inc. | 4 | $99 |
| GlaxoSmithKline, LLC. | 3 | $78 |
| Grifols USA, LLC | 3 | $72 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| HARMONY BIOSCIENCES LLC | 1 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Viatris Specialty LLC | 1 | $22 |
Products named: XYWAV, FASENRA, Ohtuvayre, TRELEGY ELLIPTA, Prolastin-C Liquid, AIRSUPRA, OPSUMIT, TEZSPIRE.
Industry payments across NY — which companies pay providers there.
